Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Wilcoxen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Combinatorial Chemistry|January 14, 2003
Automated mass spectrometric sequence determination of cyclic peptide library membersJames E Redman, Keith M Wilcoxen, M Reza Ghadiri
Personalized Medicine|May 23, 2018
Intersectional innovation in biomarker development for patient-centric medicineKeith M Wilcoxen, Jacob Hesterman, Kelly Davis Orcutt, et al.
Current Topics in Medicinal Chemistry|August 19, 2007
Recent advances of MEK inhibitors and their clinical progressJohn Yuan Wang, Keith M Wilcoxen, Kenichi Nomoto, et al.
Expert Opinion on Drug Discovery|July 25, 2012
Practical metabolomics in drug discoveryKeith M Wilcoxen, Taisuke Uehara, Khin Than Myint, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonistsCharles Q Huang, Keith M Wilcoxen, Dimitri E Grigoriadis, et al.
Journal of the American Chemical Society|February 17, 2007
Functional and mechanistic analyses of biomimetic aminoacyl transfer reactions in de novo designed coiled coil peptides via rational active site engineeringLuke J Leman, Dana A Weinberger, Zheng-Zheng Huang, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubilityChen Chen, Keith M Wilcoxen, Charles Q Huang, et al.
Bioorganic & Medicinal Chemistry|July 5, 2005
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infectionsW Seth Horne, Christopher M Wiethoff, Chunli Cui, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Synthesis and initial structure-activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonistsKeith M Wilcoxen, Yun Fei Zhu, Patrick J Connors, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonistsTimothy D Gross, Yun Fei Zhu, John Saunders, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Combinatorial Chemistry|January 14, 2003
Automated mass spectrometric sequence determination of cyclic peptide library membersJames E Redman, Keith M Wilcoxen, M Reza Ghadiri
Personalized Medicine|May 23, 2018
Intersectional innovation in biomarker development for patient-centric medicineKeith M Wilcoxen, Jacob Hesterman, Kelly Davis Orcutt, et al.
Current Topics in Medicinal Chemistry|August 19, 2007
Recent advances of MEK inhibitors and their clinical progressJohn Yuan Wang, Keith M Wilcoxen, Kenichi Nomoto, et al.
Expert Opinion on Drug Discovery|July 25, 2012
Practical metabolomics in drug discoveryKeith M Wilcoxen, Taisuke Uehara, Khin Than Myint, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonistsCharles Q Huang, Keith M Wilcoxen, Dimitri E Grigoriadis, et al.
Journal of the American Chemical Society|February 17, 2007
Functional and mechanistic analyses of biomimetic aminoacyl transfer reactions in de novo designed coiled coil peptides via rational active site engineeringLuke J Leman, Dana A Weinberger, Zheng-Zheng Huang, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubilityChen Chen, Keith M Wilcoxen, Charles Q Huang, et al.
Bioorganic & Medicinal Chemistry|July 5, 2005
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infectionsW Seth Horne, Christopher M Wiethoff, Chunli Cui, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Synthesis and initial structure-activity relationships of a novel series of imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonistsKeith M Wilcoxen, Yun Fei Zhu, Patrick J Connors, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2002
Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonistsTimothy D Gross, Yun Fei Zhu, John Saunders, et al.
Pageof 2